Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-12
1998-05-26
Furman, Keith C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 530329, 530330, C07K 704, C07K 706, A61K 3808, A61K 3817
Patent
active
057564655
ABSTRACT:
There is disclosed an isolated polypeptide and derivatives thereof having protease biological activity for human precursor IL-1.beta. and for a substrate comprising:
REFERENCES:
patent: 5104853 (1992-04-01), Beason et al.
patent: 5225354 (1993-07-01), Knowles et al.
patent: 5304481 (1994-04-01), Davies et al.
Sigma Catalog 1989 pp. 294-295, 312, 351-352.
Black et al "A Pre-asparte-specific Protease . . . ", Journal of Biological Chemistry vol. 264, No. 10 pp. 5323-5326 Apr. 5, 1989.
Malek et al. "Amino acid sequence . . . " Biochem Biophys Res Comm. 126(1) 1985 pp. 199-205 (Abstract only).
Knittel et al. "Stimulation of insulin . . . " Pept. Res. 3(5) 1990 pp. 224-227. (Abstract).
Kitada et al, "New peptide Model . . . " Chem Pharm Bull. 26(2) 1978 pp. 585-590. (Abstract).
Black Roy A.
Kronheim Shirley R.
Sleath Paul R.
Balogh Imre
Davis William J.
Furman Keith C.
Sanofi
LandOfFree
Interleukin 1.beta. protease and interleukin 1.beta. protease in does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin 1.beta. protease and interleukin 1.beta. protease in, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin 1.beta. protease and interleukin 1.beta. protease in will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960104